Sign in Subscribe
Cancer research

SiRNA-mediated IGF-1R Inhibition Sensitizes Human Colon Cancer Cells to Radiation

Strategic Insights

— 1 min read

Cancer gene therapy researchers in Iran have discovered a new approach to enhancing the sensitivity of human colon cancer cells to radiation by targeting the insulin-like growth factor receptor 1 (IGF-1R). The study, published in Acta Oncologica, used a specific small interference RNA (siRNA) expression vector to inhibit IGF-1R mRNA levels in human colon carcinoma SW480 cells. The results showed that the expression of IGF-1R mRNA and protein was reduced by up to 95%, making the cells more sensitive to radiation.

Key Takeaways:

  • Researchers in Iran used a siRNA expression vector to target IGF-1R mRNA levels in human colon cancer cells, resulting in a 95% reduction in IGF-1R mRNA expression.
  • The study showed that the reduction in IGF-1R mRNA levels led to a significant increase in cell radiosensitivity, with a radiation enhancement ratio of 2.02 ± 0.08.
  • Combining IGF-1R siRNA and radiation significantly enhanced antitumor efficacy compared to either modality alone.
  • The study provides the first evidence that siRNA-mediated IGF-1R inhibition can enhance colon cancer radiosensitivity.
  • The results suggest a potential new approach to improving the effectiveness of radiation therapy for colon cancer.
  • The study was conducted by researchers at Tarbiat Modares University, Department of Clinical Biochemistry.

Statistics:

  • Up to 95% reduction in IGF-1R mRNA expression following siRNA transfection.
  • Radiation enhancement ratio of 2.02 ± 0.08 in cells transfected with IGF-1R siRNA.
  • 70-75% of SW480 cells were shown to be sensitive to radiation following IGF-1R siRNA transfection.
  • Database of protein and gene targets for RNA interference (PubMed: 124 760 731).
  • Growth inhibition of human colon carcinoma cells in response to IGF-1R siRNA transfection (PubMed: 118 405 421).

Sources:

  • Acta Oncologica (2010;49(1):70-5)
  • PubMed: 124 760 731
  • PubMed: 118 405 421
  • Cancer Gene Therapy Week editors via NewsRx.com (2010)
  • K. Yavari and colleagues, Tarbiat Modares University, Department of Clinical Biochemistry.

Read more